[Endocrine therapy for breast cancer: past and present].
The endocrine therapy for breast cancer could be traced back to the excision of the metastatic breast cancer by oophorectomy in a premenopausal women performed by Beatson in 1896. After the development of more than 100 years, endocrine therapy plays an important role in adjuvant therapy, the rescuing treatment of its recurrence due to metastasis, and the new adjuvant endocrine therapy for breast cancer. Through analyzing the changes in the 4 aspects of endocrine treatment of breast cancer, i.e., the original simple excision of the endocrine organs, tamoxifen, drug-induced ovarian castration and the 3th generation aromatase inhibitor, the characteristics of different ages of endocrine therapy can be summarized, which would provide the reference for the new developmental trend of this therapy.
Yanshou
Y
Zhang
Yunjiang
Y
Liu
D018931:Antineoplastic Agents, Hormonal / Q000266:history* / Q000494:pharmacology / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000266:history* / Q000494:pharmacology / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000266:history*; D002681:China; D005260:Female; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D010053:Ovary / Q000187:drug effects; D013629:Tamoxifen / Q000266:history* / Q000494:pharmacology / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D013629:Tamoxifen